expert insights webinars

Award-winning experts share their detailed and actionable insights to inform the future of pharma, biotech, and medical devices

View our complimentary webinar offerings below and register for one or more webinars.

Expert Insights webinars, presented by MMS

The Expert Insights webinar series offers free learning opportunities on current trends, high-value topics, and complex initiatives in the evolving pharmaceutical, biotechnology, and medical device industries. Current and archived webinars are available as follows:

 

Tips for Efficient and Effective New Drug Application (NDA) Submissions - December 14, 2021 – 11:00 AM – 12:00 PM EST

This Expert Insights webinar will demonstrate New Drug Applications (NDAs) are the final step of a long clinical development process and the most important deliverable a pharmaceutical company produces. Submitting a complete, comprehensive, and acceptable package is complex and time-consuming. 

After supporting more than 10 NDA submissions in five years, MMS statistical programmers know how to do this efficiently and effectively. Listen and learn as our panel of global experts discuss best practices and share tips to help your next NDA submission go smoothly.  

Join us for this free webinar to learn:  

  • The many components of an NDA submission 
  • How to avoid the common programming downfalls in an NDA submission 
  • How to manage the challenges that arise when working on an NDA submission

Presenters: 

  • James Bademian, Director, Statistical Programming and Data Management 
  • Pieter Cloete, Associate Manager of Statistical Programming 
  • Saichand Satyavarapu, Senior Manager of Statistical Programming 
  • Satyapal Ingle, Associate Manager of Statistical Programming 
View all archived webinars

Quality Control of Regulatory Documents

Tips and tools for writing effective plain language summaries

Automating the Review of Aggregate Safety Data – An In-Depth Look

Preparing for an FDA inspection – what you need to know

Modernizing the Functional Service Provider (FSP) Relationship

Authoring Efficiencies and Cross-functional Strategies: Clinical Study Report and Beyond

Ensuring Success in Implementing EMA Policy 0070 and Health Canada PRCI

Benefit-Risk Assessments for Marketing Applications: Employing a Well-Structured & Thorough Approach

Best Practices for Data Visualization in Pharma

Understanding EMA Policy 0070 and Health Canada PRCI Transparency Requirements

Recommended Changes for Pharma Companies in Response to COVID-19

The Programmer Approach to Real World Data and Using Real World Evidence in Research and Healthcare

Wisdom from the Front Lines of Successful NDA Submission Programming

Optimizing the Use of Clinical Trial Disclosure Systems to Meet Complex and Evolving Global Regulatory Requirements

Transparency: Effective Data and Document Anonymization at the Intersection of Process and Technology

How to Use Machine Learning in Clinical Research Right Now

Evolving Your FSP Relationships to Achieve Maximum Return

Avoiding Common Pitfalls in the IND and CTA Submission Process

EU Clinical Trials Regulation: The Clinical Trial Transparency Revolution

The Blueprint for Success for Effective and Efficient Clinical Protocols

MMS Rare Disease Series: Rare Disease Research in the United States (Part One)

MMS Rare Disease Series: Rare Disease Research in the United States (Part Two)

Orphan Drug, Rare Pediatric Disease, and Expedited Program Designations:  FDA Incentives to Promote Rare Disease Drug Development

Strategies for Rare Disease Data Analysis: Doing More with Less

Subscribe to receive webinar updates

Name
Notify me of additional webinars and recent news

Data Management
& Biostatistics

Regulatory
& Medical Writing

Drug Safety
& Pharmacovigilance

Compliance
& Transparency

Data
Sciences